Gl Events (0IX0)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 31.45 |
|---|---|
| 52-week range | 23.60 – 35.80 |
| Return, 1 month / 3 months | +22.1% / +0.0% |
| Return, 1 year / 3 years | +12.5% / +126.2% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 52.7% |
| Worst drawdown (1 year) | -32.5% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
GL Events is a French group based in Lyon that works in the events industry. It designs and supplies temporary structures, stands and fittings for fairs, congresses and other gatherings, and it also organises trade shows and manages exhibition venues. Its customers include organisers of professional events, public bodies and companies that need staging, furniture and technical services for their gatherings in France and other countries.
On this site Gl Events appears as a stock on the London Stock Exchange (UK), code 0IX0, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gl Events (0IX0) trades on the London Stock Exchange in UK. It last closed at EUR 31.45 on 27 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,617 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.5% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | – | ||
| From 52-week high | -11.8% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | -3.7% | ||
| 12-month return, skipping the last month | -7.9% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 52.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.5% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 21.7% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | +22.1% |
| 3 months | +0.0% |
| 6 months | −3.7% |
| 1 year | +12.5% |
| 3 years | +126.2% |
| 5 years | +98.8% |
Signals
| 50-day / 200-day average | 29.80 / 30.27 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | EUR 1.0000 |
| 1 Jul 2025 | EUR 0.9000 |
| 2 Jul 2024 | EUR 0.7000 |
| 3 Jul 2023 | EUR 0.3500 |
| 1 Jul 2019 | EUR 0.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.